{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,13]],"date-time":"2025-05-13T18:08:43Z","timestamp":1747159723795,"version":"3.40.5"},"reference-count":20,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2014,9,1]],"date-time":"2014-09-01T00:00:00Z","timestamp":1409529600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["ejso.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Surgical Oncology (EJSO)"],"published-print":{"date-parts":[[2014,9]]},"DOI":"10.1016\/j.ejso.2014.03.006","type":"journal-article","created":{"date-parts":[[2014,3,26]],"date-time":"2014-03-26T12:52:22Z","timestamp":1395838342000},"page":"1151-1155","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["Weekly chemotherapy with cisplatin, vincristine, doxorubicin, and etoposide followed by surgery for thymic carcinoma"],"prefix":"10.1016","volume":"40","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6725-9127","authenticated-orcid":false,"given":"H.","family":"Kawasaki","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.","family":"Taira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Ichi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Yohena","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Kawabata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"Ishikawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejso.2014.03.006_bib1","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1097\/00000478-198210000-00003","article-title":"Primary thymic carcinomas","volume":"6","author":"Wick","year":"1982","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.ejso.2014.03.006_bib2","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1002\/1097-0142(19910215)67:4<1025::AID-CNCR2820670427>3.0.CO;2-F","article-title":"Thymic carcinoma: a clinicopathologic study of 60 cases","volume":"67","author":"Suster","year":"1991","journal-title":"Cancer"},{"key":"10.1016\/j.ejso.2014.03.006_bib3","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/S0022-5223(94)70112-1","article-title":"Thymic carcinoma: ten years' experience in twenty patients","volume":"107","author":"Hsu","year":"1994","journal-title":"J\u00a0Thorac Cardiovasc Surg"},{"key":"10.1016\/j.ejso.2014.03.006_bib4","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/S0022-5223(98)70273-9","article-title":"Thymic carcinoma: current staging does not predict prognosis","volume":"115","author":"Blumberg","year":"1998","journal-title":"J\u00a0Thorac Cardiovasc Surg"},{"key":"10.1016\/j.ejso.2014.03.006_bib5","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1097\/00000478-197706000-00002","article-title":"Squamous cell carcinoma of the thymus: an analysis of eight cases","volume":"1","author":"Shimosato","year":"1977","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.ejso.2014.03.006_bib6","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1002\/1097-0142(19930215)71:4<1219::AID-CNCR2820710408>3.0.CO;2-B","article-title":"Thymic carcinoma: a distinct clinical entity responsive to chemotherapy","volume":"71","author":"Weide","year":"1993","journal-title":"Cancer"},{"key":"10.1016\/j.ejso.2014.03.006_bib7","doi-asserted-by":"crossref","first-page":"3115","DOI":"10.1002\/cncr.10588","article-title":"Treatment and prognosis of thymic carcinoma: a retrospective analysis of 40 cases","volume":"94","author":"Ogawa","year":"2002","journal-title":"Cancer"},{"key":"10.1016\/j.ejso.2014.03.006_bib8","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1097\/JTO.0b013e3181653c71","article-title":"Thymic carcinoma: 30 cases at a single institution","volume":"3","author":"Yano","year":"2008","journal-title":"J\u00a0Thorac Oncol"},{"key":"10.1016\/j.ejso.2014.03.006_bib9","doi-asserted-by":"crossref","first-page":"2010","DOI":"10.1002\/1097-0142(20010601)91:11<2010::AID-CNCR1226>3.0.CO;2-2","article-title":"Combined etoposide, ifosfamide, and cisplatin in the treatment of patients with advanced thymoma and thymic carcinoma: an intergroup trial","volume":"91","author":"Loehrer","year":"2001","journal-title":"Cancer"},{"key":"10.1016\/j.ejso.2014.03.006_bib10","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1053\/ejso.2001.1197","article-title":"Thymic carcinoma: a report of 13 cases","volume":"27","author":"Lucchi","year":"2001","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.ejso.2014.03.006_bib11","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1097\/00000421-200206000-00012","article-title":"Chemotherapy for advanced thymic carcinoma: clinical response to cisplatin, doxorubicin, vincristine, and cyclophosphamide (ADOC chemotherapy)","volume":"25","author":"Koizumi","year":"2002","journal-title":"Am J Clin Oncol"},{"key":"10.1016\/j.ejso.2014.03.006_bib12","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1002\/cncr.11606","article-title":"Weekly chemotherapy with cisplatin, vincristine, doxorubicin, and etoposide is an effective treatment for advanced thymic carcinoma","volume":"98","author":"Yoh","year":"2003","journal-title":"Cancer"},{"key":"10.1016\/j.ejso.2014.03.006_bib13","series-title":"Histological typing of tumours of the thymus","first-page":"13","author":"Rosai","year":"1999"},{"key":"10.1016\/j.ejso.2014.03.006_bib14","doi-asserted-by":"crossref","first-page":"2485","DOI":"10.1002\/1097-0142(19811201)48:11<2485::AID-CNCR2820481123>3.0.CO;2-R","article-title":"Follow-up study of thymomas with special reference to their clinical stages","volume":"48","author":"Masaoka","year":"1981","journal-title":"Cancer"},{"key":"10.1016\/j.ejso.2014.03.006_bib15","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1093\/jnci\/92.3.205","article-title":"New guidelines to evaluate the response to treatment in solid tumors: European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada","volume":"92","author":"Therasse","year":"2000","journal-title":"J\u00a0Natl Cancer Inst"},{"first-page":"168","year":"2003","series-title":"Role for clinical and pathological record of lung cancer","key":"10.1016\/j.ejso.2014.03.006_bib16"},{"key":"10.1016\/j.ejso.2014.03.006_bib17","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1016\/S0003-4975(03)00555-1","article-title":"Therapy for thymic epithelial tumors: a clinical study of 1,320 patients from Japan","volume":"76","author":"Kondo","year":"2003","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.ejso.2014.03.006_bib18","doi-asserted-by":"crossref","first-page":"1632","DOI":"10.1200\/JCO.1991.9.9.1632","article-title":"Intensive weekly chemotherapy for the treatment of extensive-stage small-cell lung cancer","volume":"9","author":"Murray","year":"1991","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.ejso.2014.03.006_bib19","doi-asserted-by":"crossref","first-page":"2126","DOI":"10.1200\/JCO.1998.16.6.2126","article-title":"Phase III study of intensive weekly chemotherapy with recombinant human granulocyte colony-stimulating factor versus standard chemotherapy in extensive-disease small-cell lung cancer. The Japan Clinical Oncology Group","volume":"16","author":"Furuse","year":"1998","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.ejso.2014.03.006_bib20","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1038\/sj.bjc.6605731","article-title":"A\u00a0phase II trial of dose-dense chemotherapy, followed by surgical resection and\/or thoracic radiotherapy, in locally advanced thymoma: report of a Japan Clinical Oncology Group trial (JCOG 9606)","volume":"103","author":"Kunitoh","year":"2010","journal-title":"Br J Cancer"}],"container-title":["European Journal of Surgical Oncology (EJSO)"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0748798314003515?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0748798314003515?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,8,16]],"date-time":"2020-08-16T21:07:45Z","timestamp":1597612065000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0748798314003515"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,9]]},"references-count":20,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2014,9]]}},"alternative-id":["S0748798314003515"],"URL":"https:\/\/doi.org\/10.1016\/j.ejso.2014.03.006","relation":{},"ISSN":["0748-7983"],"issn-type":[{"type":"print","value":"0748-7983"}],"subject":[],"published":{"date-parts":[[2014,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Weekly chemotherapy with cisplatin, vincristine, doxorubicin, and etoposide followed by surgery for thymic carcinoma","name":"articletitle","label":"Article Title"},{"value":"European Journal of Surgical Oncology (EJSO)","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejso.2014.03.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}